Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Gene Writing Technology Market Growth Potential: How Will Market Size Shift Through 2030?
The gene writing technology market size has experienced significant expansion in recent years. It is anticipated to grow from $5.62 billion in 2025 to $7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 24.5%. This market’s historical growth can be attributed to various factors, such as advancements in chemical DNA synthesis techniques, an increase in genomics research funding, a rising demand for gene editing applications, the expansion of biopharmaceutical research activities, and the increasing adoption of synthetic biology tools.
The gene writing technology market is projected to experience substantial growth in the upcoming years. It is forecasted to expand to $16.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.8%. This growth throughout the forecast period can be attributed to several factors, including the expanding development of gene-based therapeutics, increased automation within DNA synthesis platforms, a surge in investment in agricultural biotechnology innovation, the wider adoption of AI-driven gene design tools, and the rising demand for scalable and cost-efficient DNA manufacturing. Prominent trends for the forecast period encompass the increasing uptake of enzymatic DNA synthesis methods, a growing requirement for long-sequence DNA assembly, heightened investment in synthetic biology platforms, the expansion of customized gene design services, and the greater integration of automated gene synthesis workflows.
Get A Free Sample Report With In-Depth Market Insights:
Gene Writing Technology Market Growth Backed By Core Demand Fundamentals
The expanding field of gene therapy development is projected to drive the expansion of the gene writing technology market in the future. Gene therapy development encompasses the increasing investigations, clinical trials, and regulatory authorizations for treatments aimed at correcting or treating genetic diseases through gene alteration. This development is escalating due to swift progress in genetic engineering techniques and favorable regulatory environments, which allow more therapies to advance from initial research to clinical testing and final approval. Gene writing technology plays a crucial role in gene therapy development by offering precise, efficient, and programmable instruments for editing, inserting, or correcting particular genes, thereby facilitating the creation of safer and more effective treatments for various genetic conditions. For instance, data from January 2024, reported by the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, revealed that in fourth quarter (Q4) 2023, the count of gene therapies in Phase III saw a 10% increase compared to the prior quarter, representing the first upturn since third quarter (Q3) 2022. Consequently, the rising gene therapy development is boosting the gene writing technology market’s growth.
Gene Writing Technology Market Segment Analysis: What Are The Core Market Categories?
The gene writing technology market covered in this report is segmented –
1) By Technology: Chemical Deoxyribonucleic Acid Synthesis, Enzymatic Deoxyribonucleic Acid Synthesis
2) By Product Type: Gene Editing Tools, Gene Synthesis Platforms, Delivery Systems, Other Product Types
3) By Application: Therapeutics, Research, Agriculture, Diagnostics
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End Users
Subsegments:
1) By Chemical Deoxyribonucleic Acid Synthesis: Solid Phase Synthesis, Liquid Phase Synthesis, Microarray Based Synthesis, Chip Based Synthesis
2) By Enzymatic Deoxyribonucleic Acid Synthesis: Polymerase Mediated Synthesis, Ligase Mediated Synthesis, Recombinase Mediated Synthesis, Template Independent Synthesis
Gene Writing Technology Market Growth Trends Reshaping The Competitive Landscape
Leading firms in the gene writing technology market are concentrating on creating innovative solutions, such as in vivo gene editing therapy, to accurately rectify disease-causing genes and offer lasting treatments for genetic disorders. This therapy involves directly altering a patient’s genes within their body to amend disease-causing mutations, thereby delivering exact, enduring remedies for genetic disorders without requiring repetitive treatments. An example is Tessera Therapeutics Inc., a US-based biotechnology company, which revealed the progression of TSRA-196, an in vivo gene writing-based therapy aimed at alpha-1 antitrypsin deficiency (AATD), in January 2026. TSRA-196 is formulated for intravenous delivery, utilizing the company’s unique lipid nanoparticle system to transport RNA to liver cells. Developed on a target-primed reverse transcription (TPRT) platform, this therapy seeks to permanently rectify the underlying SERPINA1 gene mutation, potentially restoring functional AAT protein expression. This method endeavors to surpass the drawbacks of conventional augmentation therapies, which only offer temporary relief for symptoms.
Gene Writing Technology Market Competitive Overview And Top Companies
Major companies operating in the gene writing technology market are Beam Therapeutics Inc., Twist Bioscience Corporation, Sangamo Therapeutics Inc., Editas Medicine Inc., Tessera Therapeutics Inc., Precision BioSciences Inc., Metagenomi Inc., Mammoth Biosciences Inc., Synbio Technologies Inc., Arbor Biotechnologies Inc., Intellia Therapeutics Inc., Inscripta Inc., Edigene Inc., Recombinetics Inc., Pairwise Plants Inc., Caribou Biosciences Inc., GenEdit Inc., BRL Medicine Inc., Eligo Bioscience Inc., Prime Medicine Inc., ToolGen Inc., iECURE Inc., Cellectis S.A.
View The Full Gene Writing Technology Market Report:
Gene Writing Technology Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the gene writing technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene writing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model